Welcome to Novo Nordisk in the United States

file

About the author:

Matthias von Herrath, MD, is vice president of Novo Nordisk’s type 1 diabetes team at the company’s Seattle research center. Matthias leads a diabetes translational unit, which is based on less conventional and innovative design for immune-based interventions.

Entries by Matthias von Herrath

    What it’s like to GOBOLDLY every day

    26 September 2017

    Matthias von Herrath, MD, Vice President of Novo Nordisk’s Diabetes R&D Center in Seattle, is one of the researchers featured in the GOBOLDLY campaign from the biopharmaceutical industry group, PhRMA. GOBOLDLY highlights the value America’s pharmaceutical companies bring to patients, society, and our economy.

    In this Q&A, Matthias shares some behind-the-scenes stories about his role with the campaign and what it’s really like to be on the front lines of finding a cure for diabetes.

     
    Read more